Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $4.44B | $156.88 | 0.77% | $17.90M | 392.20x | 0.05 | |
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $2.08B | $13.47 | -3.16% | $25.89M | 149.67x | 1.05 | |
| GMAB | GENMAB A | NASDAQ | Biotechnology | $18.60B | $28.15 | 2.51% | N/A | 29.02x | 0.12 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.66B | $29.32 | 1.35% | $221.51M | 13.51x | 0.74 | |
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $921.43M | $6.27 | 0.40% | $32.57M | 15.68x | 0.68 | |
| VNDA | VANDA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $265.82M | $4.62 | 3.13% | $9.35M | 115.50x | 0.19 | |
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $2.36B | $22.80 | 2.66% | $109.00M | 22.35x | 0.23 | |
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $4.89B | $38.57 | 0.29% | $451.95M | 18.11x | 19.68 | |
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $16.73B | $28.00 | -0.39% | $1.32B | 11.02x | 0.62 | |
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $11.60B | $51.68 | 0.98% | $919.43M | 19.36x | 0.31 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $15.36B | $80.91 | -1.53% | $359.85M | 74.23x | 0.36 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $6.82B | $109.46 | 1.89% | $1.22B | 16.71x | 2.05 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $119.30M | $1.76 | -1.12% | $55.39M | 2.41x | 0.19 | |
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $7.19B | $23.70 | 0.72% | $312.21M | 36.46x | 0.30 | |
| PBYI | PUMA BIOTECHNOLOGY INC | NASDAQ | Biotechnology | $242.00M | $5.02 | 2.87% | $47.52M | 10.91x | 3.31 | |
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $10.07B | $64.06 | 2.23% | $372.91M | 45.43x | 0.39 | |
| BNTX | BIONTECH SE | NASDAQ | Biotechnology | $20.73B | $87.21 | 0.58% | $1.51B | 20.73x | 0.14 | |
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.75B | $14.89 | 1.43% | $127.65M | 22.22x | 0.21 | |
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $572.09B | $126.85 | 0.84% | $16.66B | 46.67x | 1.95 | |
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $11.00B | $233.85 | -0.89% | $1.39B | 11.11x | 0.20 | |
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $96.94B | $883.20 | -0.84% | $4.69B | 23.84x | 0.27 | |
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $102.67B | $397.48 | -0.06% | $4.61B | 28.29x | 0.29 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.